125 related articles for article (PubMed ID: 18347138)
1. Anticancer properties of the novel nitric oxide-donating compound (S,R)-3-phenyl-4,5-dihydro-5-isoxazole acetic acid-nitric oxide in vitro and in vivo.
Maksimovic-Ivanic D; Mijatovic S; Harhaji L; Miljkovic D; Dabideen D; Fan Cheng K; Mangano K; Malaponte G; Al-Abed Y; Libra M; Garotta G; Nicoletti F; Stosic-Grujicic S
Mol Cancer Ther; 2008 Mar; 7(3):510-20. PubMed ID: 18347138
[TBL] [Abstract][Full Text] [Related]
2. Novel nitric oxide-donating compound (S,R)-3-phenyl-4,5-dihydro-5-isoxazole acetic acid-nitric oxide (GIT-27NO) induces p53 mediated apoptosis in human A375 melanoma cells.
Mijatovic S; Maksimovic-Ivanic D; Mojic M; Malaponte G; Libra M; Cardile V; Miljkovic D; Harhaji L; Dabideen D; Cheng KF; Bevelacqua Y; Donia M; Garotta G; Al-Abed Y; Stosic-Grujicic S; Nicoletti F
Nitric Oxide; 2008 Sep; 19(2):177-83. PubMed ID: 18460348
[TBL] [Abstract][Full Text] [Related]
3. The novel NO-donating compound GIT-27NO inhibits in vivo growth of human prostate cancer cells and prevents murine immunoinflammatory hepatitis.
Donia M; Mijatovic S; Maksimovic-Ivanic D; Miljkovic D; Mangano K; Tumino S; Biondi A; Basile F; Al-Abed Y; Stosic-Grujicic S; Nicoletti F
Eur J Pharmacol; 2009 Aug; 615(1-3):228-33. PubMed ID: 19446546
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic potential of nitric oxide-modified drugs in colon cancer cells.
Mojic M; Mijatovic S; Maksimovic-Ivanic D; Miljkovic D; Stosic-Grujicic S; Stankovic M; Mangano K; Travali S; Donia M; Fagone P; Zocca MB; Al-Abed Y; McCubrey JA; Nicoletti F
Mol Pharmacol; 2012 Oct; 82(4):700-10. PubMed ID: 22798453
[TBL] [Abstract][Full Text] [Related]
5. Induction of caspase-independent apoptotic-like cell death of mouse mammary tumor TA3Ha cells in vitro and reduction of their lethality in vivo by the novel chemotherapeutic agent GIT-27NO.
Mijatovic S; Maksimovic-Ivanic D; Timotijevic G; Miljkovic D; Donia M; Libra M; Coco M; McCubrey J; Al-Abed Y; Korac A; Stosic-Grujicic S; Nicoletti F
Free Radic Biol Med; 2010 Apr; 48(8):1090-9. PubMed ID: 20114073
[TBL] [Abstract][Full Text] [Related]
6. Effects of GIT-27NO, a NO-donating compound, on hepatic ischemia/reperfusion injury.
Mangano K; Lanteri R; Basile MS; Bellavia N; Latino R; Messina D; Fagone P; Colletti G; Nania R; Caltabiano R; Di Marco R; Di Cataldo A
Int J Immunopathol Pharmacol; 2019; 33():2058738419862736. PubMed ID: 31298048
[TBL] [Abstract][Full Text] [Related]
7. A potent immunomodulatory compound, (S,R)-3-Phenyl-4,5-dihydro-5-isoxazole acetic acid, prevents spontaneous and accelerated forms of autoimmune diabetes in NOD mice and inhibits the immunoinflammatory diabetes induced by multiple low doses of streptozotocin in CBA/H mice.
Stosic-Grujicic S; Cvetkovic I; Mangano K; Fresta M; Maksimovic-Ivanic D; Harhaji L; Popadic D; Momcilovic M; Miljkovic D; Kim J; Al-Abed Y; Nicoletti F
J Pharmacol Exp Ther; 2007 Mar; 320(3):1038-49. PubMed ID: 17148780
[TBL] [Abstract][Full Text] [Related]
8. In vitro, ex vivo and in vivo immunopharmacological activities of the isoxazoline compound VGX-1027: modulation of cytokine synthesis and prevention of both organ-specific and systemic autoimmune diseases in murine models.
Stojanovic I; Cuzzocrea S; Mangano K; Mazzon E; Miljkovic D; Wang M; Donia M; Al Abed Y; Kim J; Nicoletti F; Stosic-Grujicic S; Claesson M
Clin Immunol; 2007 Jun; 123(3):311-23. PubMed ID: 17449326
[TBL] [Abstract][Full Text] [Related]
9. Anticancer properties of Ganoderma lucidum methanol extracts in vitro and in vivo.
Harhaji Trajković LM; Mijatović SA; Maksimović-Ivanić DD; Stojanović ID; Momcilović MB; Tufegdzić SJ; Maksimović VM; Marjanović ZS; Stosić-Grujicić SD
Nutr Cancer; 2009; 61(5):696-707. PubMed ID: 19838944
[TBL] [Abstract][Full Text] [Related]
10. The antitumor properties of a nontoxic, nitric oxide-modified version of saquinavir are independent of Akt.
Maksimovic-Ivanic D; Mijatovic S; Miljkovic D; Harhaji-Trajkovic L; Timotijevic G; Mojic M; Dabideen D; Cheng KF; McCubrey JA; Mangano K; Al-Abed Y; Libra M; Garotta G; Stosic-Grujicic S; Nicoletti F
Mol Cancer Ther; 2009 May; 8(5):1169-78. PubMed ID: 19417156
[TBL] [Abstract][Full Text] [Related]
11. Iron down-regulates macrophage anti-tumour activity by blocking nitric oxide production.
Harhaji L; Vuckovic O; Miljkovic D; Stosic-Grujicic S; Trajkovic V
Clin Exp Immunol; 2004 Jul; 137(1):109-16. PubMed ID: 15196250
[TBL] [Abstract][Full Text] [Related]
12. Licofelone-nitric oxide donors as anticancer agents.
Liu W; Zhou J; Liu Y; Liu H; Bensdorf K; Guo C; Gust R
Arch Pharm (Weinheim); 2011 Aug; 344(8):487-93. PubMed ID: 21681808
[TBL] [Abstract][Full Text] [Related]
13. Lopinavir-NO, a nitric oxide-releasing HIV protease inhibitor, suppresses the growth of melanoma cells in vitro and in vivo.
Paskas S; Mazzon E; Basile MS; Cavalli E; Al-Abed Y; He M; Rakocevic S; Nicoletti F; Mijatovic S; Maksimovic-Ivanic D
Invest New Drugs; 2019 Oct; 37(5):1014-1028. PubMed ID: 30706336
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, and antitumor evaluation of novel histone deacetylase inhibitors equipped with a phenylsulfonylfuroxan module as a nitric oxide donor.
Duan W; Li J; Inks ES; Chou CJ; Jia Y; Chu X; Li X; Xu W; Zhang Y
J Med Chem; 2015 May; 58(10):4325-38. PubMed ID: 25906087
[TBL] [Abstract][Full Text] [Related]
15. Metformin reduces cisplatin-mediated apoptotic death of cancer cells through AMPK-independent activation of Akt.
Janjetovic K; Vucicevic L; Misirkic M; Vilimanovich U; Tovilovic G; Zogovic N; Nikolic Z; Jovanovic S; Bumbasirevic V; Trajkovic V; Harhaji-Trajkovic L
Eur J Pharmacol; 2011 Jan; 651(1-3):41-50. PubMed ID: 21114978
[TBL] [Abstract][Full Text] [Related]
16. NG as a novel nitric oxide donor induces apoptosis by increasing reactive oxygen species and inhibiting mitochondrial function in MGC803 cells.
Liu L; Li T; Tan J; Fu J; Guo Q; Ji H; Zhang Y
Int Immunopharmacol; 2014 Nov; 23(1):27-36. PubMed ID: 25135879
[TBL] [Abstract][Full Text] [Related]
17. Novel anticancer oridonin derivatives possessing a diazen-1-ium-1,2-diolate nitric oxide donor moiety: Design, synthesis, biological evaluation and nitric oxide release studies.
Xu S; Wang G; Lin Y; Zhang Y; Pei L; Yao H; Hu M; Qiu Y; Huang Z; Zhang Y; Xu J
Bioorg Med Chem Lett; 2016 Jun; 26(12):2795-2800. PubMed ID: 27158140
[TBL] [Abstract][Full Text] [Related]
18. The nitric oxide-donating pravastatin derivative, NCX 6550 [(1S-[1alpha(betaS*, deltaS*), 2alpha, 6alpha, 8beta-(R*), 8a alpha]]-1,2,6,7,8,8a-Hexahydro-beta, delta, 6-trihydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1-naphtalene-heptanoic acid 4-(nitrooxy)butyl ester)], reduces splenocyte adhesion and reactive oxygen species generation in normal and atherosclerotic mice.
Dever G; Spickett CM; Kennedy S; Rush C; Tennant G; Monopoli A; Wainwright CL
J Pharmacol Exp Ther; 2007 Jan; 320(1):419-26. PubMed ID: 17005918
[TBL] [Abstract][Full Text] [Related]
19. Nitric oxide photorelease from a trinuclear ruthenium nitrosyl complex and its in vitro cytotoxicity against melanoma cells.
Carneiro ZA; Biazzotto JC; Alexiou AD; Nikolaou S
J Inorg Biochem; 2014 May; 134():36-8. PubMed ID: 24522147
[TBL] [Abstract][Full Text] [Related]
20. Characterization of thimet oligopeptidase and neurolysin activities in B16F10-Nex2 tumor cells and their involvement in angiogenesis and tumor growth.
Paschoalin T; Carmona AK; Rodrigues EG; Oliveira V; Monteiro HP; Juliano MA; Juliano L; Travassos LR
Mol Cancer; 2007 Jul; 6():44. PubMed ID: 17620116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
